Isolation and Identification of Antimicrobial Resistance of Proteus Mirabilis in Patients with Community-Acquired Urinary Tract Infections

This study was carried out in Red sea state, Sudan during the period from November 2016 to March 2017, to investigate antimicrobial resistance of P.mirabilis isolated from patients suffering from community-acquired urinary tract infections. Two hundred and nineteen urine specimens were collected from patients attended Port Sudan Teaching Hospital, Red Sea Diagnostic Centre, Sea port corporation specialized Hospital and Prince Osman Digna Teaching Hospital. Out of the two hundred and nineteen urine specimens examined, only 10 (4.6%) P.mirabilis were recovered. The result indicated that the MIC, MIC50 and MIC90 of amoxyclav were (4 µg/ml each), co-trimoxazole (0.5- 4 µg/ml, 0.5 µg/ml and 4 µg/ml), ceftriaxone (0.008- 0.08 µg/ml, 0.008 µg/ml and 0.08 µg/ml) and ciprofloxacin (0.001- 0.01µg/ml, 0.001 µg/ml and 0.0 µg/ml). The study conducted that the responsibility of P.mirabilis to UTIs slightly higher than previously recorded. The antimicrobial resistance of P.mirabilis to traditionally used antibiotics was high too.